• Home
  • News
    • Politics & Government
    • Business & Economy
    • Crime / Courts
    • Health / Medicine
  • Sports
    • High School Sports
    • Radio Iowa Poll
  • Affiliates
    • Affiliate Support Page
  • Contact Us
    • Reporters

Radio Iowa

Iowa's Radio News Network

You are here: Home / Crime / Courts / Drug company agrees to pay up in price-fixing scheme

Drug company agrees to pay up in price-fixing scheme

July 13, 2000 By admin

Iowa is winning more than a million-and-a-half dollars in a legal settlement with a prescription drug company. Bob Brammer, spokesman for the Iowa Attorney General, says Mylan Laboratories broke the law in creating a monopoly on a pair of drugs used to treat anxiety.Brammer says the Pittsburgh, Pennsylvania-based company cornered the market, then raised the price on the drugs by two-thousand to three-thousand percent. Not only was that illegal, but Brammer says it’s unconscionable.as the drugs were often used in nursing homes and for hospice patients and people with Alzheimer’s Disease. The drug’s names are clorazepate and lorazepam.Brammer says Mylan has settled the suit and will make payments of about 100-million dollars to several states where the drugs were sold. Iowa’s share should be around one-point-six million dollars.

Share this:

  • Facebook
  • Twitter

Filed Under: Crime / Courts

Featured Stories

Governor hails passage of ‘transformational’ state government reorganization

Economic impact of Iowa casinos tops one billion dollars

State board approves millions in settlement with former Hawkeye football players

Monroe County man dies while serving prison term for killing brother

Bill would make changes in Iowa’s workplace drug testing law

TwitterFacebook
Tweets by RadioIowa

Ogundele and Ulis are leaving the Iowa basketball program

Iowa plays Auburn in NCAA Tournament

Volunteers help pull off NAIA Women’s basketball championship in Sioux City

Iowa State plays Kansas in Big 12 semis

Hawkeyes must wait after early exit

More Sports

Archives

Copyright © 2023 ยท Learfield News & Ag, LLC